Market Access
Industry Problems
Strategy to focus on key Payer institutions based on client’s product positioning and competitors
Identification of key formulary decision makers like P&T members, DURB members and also advisors and influencers from these key payer institutions
Understanding the network between these key decision makers and advisors and how they are connected to top KOLs
Strategy of engaging and communicating messages to the decision makers through KOLs
Market Access has become the most important step in the drug development in today’s ever evolving market.
Neolytica partners with you to identify and engage key stakeholders that are decision makers from the key Centers of Excellence to strengthen your market access strategy. We help you fortify your clinical development efforts by supporting through a strong market launch.
Identify Top Payers and Decision Makers
- Analyze the targeted patient population and claims data to identify top payer organizations and the decision-making process in such payer organizations. Identify and map key stakeholders internally as well as externally who can influence the formulary placement in these organizations.
Maximize the Sphere of Influence
- Unleash new connections and influence of stakeholders and intra-connections of highly connected market access community and utilize client KOLs to communicate message to decision makers.
Identify The Biggest Advocates of client product and Competitor
- Learn about current and past partnerships of key advocates that might shape future decisions or restrict future access.
Payer Strategy in Key Accounts
- Understanding the existing payer environment in Key accounts to make pre and post launch decisions around payment models, contracting and reimbursement.
